OpenAI Launches GPT-Rosalind AI Model for Drug Discovery and Life Sciences Research

OpenAI has introduced GPT-Rosalind, an AI model aimed at drug discovery and life sciences. At the RSA Conference, Proofpoint's CEO Sumit Dhawan emphasized the necessity for AI regulations, while HackerOne's CEO Kara Sprague revealed a new strategic focus. Rinki Sethi from Upwind examined AI's influence on cybersecurity, and Richard Seewald of Evolution Equity discussed the wider implications of AI technology. The S&P 500 ended above 7,000, rebounding from geopolitical issues. Stellantis and Microsoft established a five-year AI collaboration. Teva issued a recall for 300,000 blood pressure patches, and Ram recalled 65,000 trucks due to a software flaw. Eli Lilly's Foundayo passed a heart safety evaluation, and Hims & Hers shares climbed 14% following an FDA review announcement.